Article
Minor Histocompatibility Antigens
1 Jan 2004
Abstract excerpt
Minor histocompatibility antigens have to be considered as key molecules in the stem cell-based immunotherapy of malignancies. Allogeneic stem cell transplantation (SCT) is a well-established and effective therapy for advanced hematologic malignancies. The apparent powerful graft-versus-leukemia effect of SCT led clinicians to apply SCT for the treatment of metastatic solid tumors. The SCT-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
